Spruce Biosciences, Inc. (SPRB) Q3 2024 Earnings
SPRB·Reported November 11, 2024·Before market open
Spruce Biosciences, Inc. reported Q3 2024 revenue of $602.0K, beat analyst consensus of $333.3K by $268.7K. Diluted EPS came in at $-15.79, beat the $-20.30 consensus by $4.51.
Revenue
$602.0Kbeat by $268.7K
Consensus: $333.3KDiluted EPS
$-15.79beat by $4.51
Consensus: $-20.30
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Spruce Biosciences, Inc. 's Q3 2024 earnings report.
Spruce Biosciences, Inc. (SPRB) reported Q3 2024 earnings on November 11, 2024 before market open.
Spruce Biosciences, Inc. reported revenue of $602.0K and diluted EPS of $-15.79 for Q3 2024.
Revenue beat the consensus estimate of $333.3K by $268.7K. EPS beat the consensus estimate of $-20.30 by $4.51.
You can read the 10-Q periodic report (0000950170-24-124479) directly on SEC EDGAR. The filing index links above go to sec.gov.